Avi Biopharma Inc (AVII)

This Washington-based (state, not Washington D.C.) drugmaker Avi makes the heart happy with its cardiovascular drugs. AVI also specializes in RNA-based therapeutics that help fight diseases ranging from Duchenne muscular dystrophy to Ebola. (Yikes!)

Show Chart

Events

  • August 82012
    AVI Biopharma, Inc. expected to report Q2 2012 results on August 8, 2012. This event was calculated by Capital IQ (Created on May 13, 2012).
  • March 92013
    AVI Biopharma, Inc. expected to report Fiscal Year 2012 results on March 9, 2013. This event was calculated by Capital IQ (Created on May 13, 2012).

Members who own this company also own

the fun, safe & free way to learn the stock market Free! Sign up now! or log in

Current price per share

Today's gain: $0.02 (2.70%)

Is this a fair price given publicly available information?
(Not an indicator of whether the price will go up or down.)
Close Icon

Sign up or Sign in or continue to Explore We Seed